Hospice Medical Director Certification Board – Trademark Portfolio
Entity Type: 99
Hospice Medical Director Certification Board owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as HMDC, HOSPICE MEDICAL DIRECTOR CERTIFIED, and HOSPICE MEDICAL DIRECTOR CERTIFICATION BOARD. Of these, 3 are registered. The portfolio spans 1 Nice Classification class, led by Class 42 (Computer & Scientific). Headquartered in Chicago, IL.
8735 W. Higgins Road, Suite 300
Chicago, IL 60631
Showing of trademarks Trademarks
Trademark Classifications
Hospice Medical Director Certification Board's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Hospice Medical Director Certification Board have?
Hospice Medical Director Certification Board has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Hospice Medical Director Certification Board file in?
Hospice Medical Director Certification Board files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Hospice Medical Director Certification Board's most well-known trademarks?
Hospice Medical Director Certification Board's registered trademark portfolio includes well-known marks such as HMDC, HOSPICE MEDICAL DIRECTOR CERTIFIED, and HOSPICE MEDICAL DIRECTOR CERTIFICATION BOARD. These are among 3 currently registered trademarks in the portfolio.
What is Hospice Medical Director Certification Board's trademark registration success rate?
Hospice Medical Director Certification Board has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.